A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort,Expert Review of Clinical Immunology

当前位置： X-MOL 学术 › Expert Rev. Clin. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2023-12-19 , DOI: 10.1080/1744666x.2023.2294040
Philippe Devillier ₁ , Mathieu Molimard ₂ , Jean-François Bergmann ₃ , Bertrand Delaisi ₄ , Amandine Gouverneur ₅ , Jade Vadel ₅ , Cédric Collin ₅ , Laurence Girard ₆ , Silvia Scurati ₆ , Pascal Demoly ₇

Affiliation

The only causal treatment for allergic rhinitis (AR) is allergen immunotherapy (AIT) including personalized liquid sublingual AIT (SLIT). We present the methodology for establishing the EfficAPSI c...

中文翻译：